Trial NCT05249569

View at ClinicalTrials.gov 
Org. Study IDs: STU-2022-0116

Last trial update was posted on 2023-05-03

MeSH Interventions

Avelumab Axitinib Bavituximab

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular

Other Conditions

Hepatocellular Carcinoma

Stopping Reasons

Sponsor pulled support for one of the study drugs.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID